Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.


Journal

Journal of hematology & oncology
ISSN: 1756-8722
Titre abrégé: J Hematol Oncol
Pays: England
ID NLM: 101468937

Informations de publication

Date de publication:
28 06 2022
Historique:
received: 30 01 2022
accepted: 13 06 2022
entrez: 28 6 2022
pubmed: 29 6 2022
medline: 1 7 2022
Statut: epublish

Résumé

Cancer is one of the leading causes of death worldwide, and the factors responsible for its progression need to be elucidated. Exosomes are structures with an average size of 100 nm that can transport proteins, lipids, and nucleic acids. This review focuses on the role of exosomes in cancer progression and therapy. We discuss how exosomes are able to modulate components of the tumor microenvironment and influence proliferation and migration rates of cancer cells. We also highlight that, depending on their cargo, exosomes can suppress or promote tumor cell progression and can enhance or reduce cancer cell response to radio- and chemo-therapies. In addition, we describe how exosomes can trigger chronic inflammation and lead to immune evasion and tumor progression by focusing on their ability to transfer non-coding RNAs between cells and modulate other molecular signaling pathways such as PTEN and PI3K/Akt in cancer. Subsequently, we discuss the use of exosomes as carriers of anti-tumor agents and genetic tools to control cancer progression. We then discuss the role of tumor-derived exosomes in carcinogenesis. Finally, we devote a section to the study of exosomes as diagnostic and prognostic tools in clinical courses that is important for the treatment of cancer patients. This review provides a comprehensive understanding of the role of exosomes in cancer therapy, focusing on their therapeutic value in cancer progression and remodeling of the tumor microenvironment.

Identifiants

pubmed: 35765040
doi: 10.1186/s13045-022-01305-4
pii: 10.1186/s13045-022-01305-4
pmc: PMC9238168
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

83

Subventions

Organisme : Singapore Ministry of Education Tier 2
ID : MOE-T2EP30120-0016
Organisme : Universiti Kebangsaan Malaysia
ID : GUP-2020-076
Organisme : Ministry of Higher Education, Malaysia
ID : FRGS/1/2019/SKK08/UKM/02/9

Informations de copyright

© 2022. The Author(s).

Références

Int J Clin Exp Pathol. 2015 May 01;8(5):5062-70
pubmed: 26191200
Nat Rev Clin Oncol. 2018 May;15(5):325-340
pubmed: 29508855
Curr Vasc Pharmacol. 2017;15(6):503-519
pubmed: 28707601
Cancer Lett. 2021 Mar 1;500:253-262
pubmed: 33221454
Cancer Sci. 2018 Mar;109(3):629-641
pubmed: 29285843
Oncogene. 2020 Jan;39(2):428-442
pubmed: 31485019
Int J Nanomedicine. 2020 Oct 28;15:8331-8343
pubmed: 33149579
Mol Ther Nucleic Acids. 2021 Feb 26;24:610-621
pubmed: 33898109
Front Pharmacol. 2016 Oct 25;7:395
pubmed: 27826244
Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2650-2658
pubmed: 28678319
Hepatology. 2021 Apr;73(4):1365-1380
pubmed: 32594528
PLoS One. 2016 Apr 20;11(4):e0153155
pubmed: 27097161
Mol Ther Nucleic Acids. 2021 Feb 03;23:1217-1228
pubmed: 33664999
Nutrients. 2018 May 19;10(5):
pubmed: 29783752
BMC Mol Cell Biol. 2021 Jan 20;22(1):6
pubmed: 33472586
Oncol Lett. 2017 Sep;14(3):3082-3088
pubmed: 28928845
Expert Opin Investig Drugs. 2010 Jan;19(1):27-43
pubmed: 20001553
Onco Targets Ther. 2019 Nov 06;12:9329-9339
pubmed: 31807013
Exp Cell Res. 2018 Jan 15;362(2):386-393
pubmed: 29223442
J Extracell Vesicles. 2018 Dec 28;8(1):1560809
pubmed: 30651940
Cancer Lett. 2020 Oct 10;490:143-153
pubmed: 32634449
J Cell Mol Med. 2020 May;24(9):5028-5038
pubmed: 32301277
Apoptosis. 2013 Oct;18(10):1175-87
pubmed: 23700228
Sci Transl Med. 2014 Dec 3;6(265):265sr6
pubmed: 25473038
Cell Death Dis. 2018 May 3;9(5):513
pubmed: 29725020
Cell Signal. 2020 Sep;73:109675
pubmed: 32446904
Exp Cell Res. 2020 Jun 15;391(2):111983
pubmed: 32268136
Comput Math Methods Med. 2021 May 24;2021:5517747
pubmed: 34122615
Nanoscale. 2020 Jan 2;12(2):877-887
pubmed: 31833519
Gastroenterology. 2020 Dec;159(6):2163-2180.e6
pubmed: 32814111
Onco Targets Ther. 2020 Aug 25;13:8651-8663
pubmed: 32904666
Arch Biochem Biophys. 2021 Sep 30;709:108965
pubmed: 34129838
Biomaterials. 2021 Jan;268:120546
pubmed: 33253966
Biomedicines. 2020 Jul 16;8(7):
pubmed: 32708613
Clin Lab. 2020 Dec 1;66(12):
pubmed: 33337849
Dev Cell. 2011 Jul 19;21(1):77-91
pubmed: 21763610
Nat Rev Cancer. 2020 Dec;20(12):697-709
pubmed: 32958932
Cells. 2019 Sep 30;8(10):
pubmed: 31575017
FASEB J. 2020 Jun;34(6):8442-8458
pubmed: 32350913
Signal Transduct Target Ther. 2020 Aug 25;5(1):166
pubmed: 32843638
Breast. 2019 Aug;46:64-69
pubmed: 31100572
Biochim Biophys Acta. 2010 Apr;1805(2):167-80
pubmed: 20079806
Cytokine Growth Factor Rev. 2020 Oct;55:70-79
pubmed: 32540133
Heliyon. 2020 Jul 02;6(7):e04138
pubmed: 32642575
Nat Rev Immunol. 2002 Aug;2(8):569-79
pubmed: 12154376
Biochem Soc Trans. 2018 Aug 20;46(4):773-778
pubmed: 29903934
Oncotarget. 2017 Jun 28;8(38):63461-63483
pubmed: 28969005
Mol Cancer. 2017 Jul 25;16(1):132
pubmed: 28743280
Mol Ther Nucleic Acids. 2019 Dec 6;18:232-244
pubmed: 31563120
Onco Targets Ther. 2021 Apr 19;14:2727-2739
pubmed: 33907416
Nat Rev Mol Cell Biol. 2016 Apr;17(4):205-11
pubmed: 26908011
Small. 2020 Mar;16(9):e1903916
pubmed: 31663295
Genes (Basel). 2017 Nov 28;8(12):
pubmed: 29182528
Int J Nanomedicine. 2020 Aug 26;15:6485-6502
pubmed: 32922012
Cell Biol Int. 2021 Sep;45(9):1807-1831
pubmed: 33913604
J Adv Res. 2021 Mar 20;35:245-257
pubmed: 35024200
Cancer Immunol Immunother. 2021 May;70(5):1323-1339
pubmed: 33140190
J Ovarian Res. 2021 Jan 7;14(1):7
pubmed: 33413589
PeerJ. 2020 Jul 20;8:e9524
pubmed: 33062407
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):393-407
pubmed: 31913710
Oncogene. 2020 Nov;39(46):7005-7018
pubmed: 33060856
Chin J Cancer Res. 2020 Oct 31;32(5):564-579
pubmed: 33223752
Cell Mol Life Sci. 2019 May;76(9):1641-1652
pubmed: 30539200
J Exp Clin Cancer Res. 2019 Feb 15;38(1):81
pubmed: 30770776
Int J Mol Sci. 2021 Jan 04;22(1):
pubmed: 33406804
Clin Transl Med. 2021 Jan;11(1):e279
pubmed: 33463054
J Extracell Vesicles. 2014 Aug 04;3:
pubmed: 25143819
Biosci Biotechnol Biochem. 2016 Nov;80(11):2122-2131
pubmed: 27362887
Oncogene. 2018 Aug;37(31):4239-4259
pubmed: 29713056
Semin Cancer Biol. 2021 Sep;74:105-120
pubmed: 33989735
Cancers (Basel). 2018 Dec 27;11(1):
pubmed: 30591679
Biomed Pharmacother. 2022 Apr;148:112743
pubmed: 35228065
Int J Nanomedicine. 2018 Oct 04;13:6049-6058
pubmed: 30323592
Cell Oncol (Dordr). 2020 Feb;43(1):123-136
pubmed: 31713003
Cancers (Basel). 2021 Mar 04;13(5):
pubmed: 33806538
Nat Commun. 2020 Jan 7;11(1):36
pubmed: 31911580
Int J Cancer. 2019 Jun 15;144(12):3111-3126
pubmed: 30536597
Oncotarget. 2017 Dec 13;9(7):7398-7410
pubmed: 29484119
Int J Mol Sci. 2020 Aug 24;21(17):
pubmed: 32847103
Carbohydr Polym. 2021 May 15;260:117809
pubmed: 33712155
Cancer Res. 2016 Apr 1;76(7):1770-80
pubmed: 26992424
Signal Transduct Target Ther. 2020 Sep 8;5(1):193
pubmed: 32900991
Int J Mol Sci. 2020 Sep 13;21(18):
pubmed: 32933173
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Oncoimmunology. 2018 Jan 16;7(4):e1412909
pubmed: 29632728
Cell Death Dis. 2021 Feb 24;12(2):210
pubmed: 33627627
J Cell Physiol. 2020 May;235(5):4135-4145
pubmed: 31637721
J Cancer. 2019 Jun 2;10(13):2892-2906
pubmed: 31281466
Oncol Lett. 2014 May;7(5):1576-1580
pubmed: 24765179
Cancer Immunol Res. 2018 Dec;6(12):1578-1592
pubmed: 30396909
Int J Mol Sci. 2021 Jun 09;22(12):
pubmed: 34207762
J Extracell Vesicles. 2021 Jan;10(3):e12056
pubmed: 33489015
Cancers (Basel). 2020 Oct 28;12(11):
pubmed: 33126572
Trends Cell Biol. 2009 Feb;19(2):43-51
pubmed: 19144520
Mol Cancer. 2019 Aug 13;18(1):124
pubmed: 31409361
Biomed Pharmacother. 2022 Jan;145:112265
pubmed: 34749054
Cancer Res. 2019 Jul 1;79(13):3503-3513
pubmed: 31097475
Nucleic Acid Ther. 2021 Oct;31(5):364-374
pubmed: 33999716
Cell Oncol (Dordr). 2017 Oct;40(5):457-470
pubmed: 28741069
Blood. 2004 Nov 1;104(9):2761-6
pubmed: 15242875
Oncotarget. 2017 May 30;8(22):36137-36148
pubmed: 28410224
Cells. 2021 Jan 12;10(1):
pubmed: 33445713
Microorganisms. 2020 Nov 12;8(11):
pubmed: 33198173
Cancer Cell Int. 2017 Jun 6;17:62
pubmed: 28592924
Hepatology. 2021 Nov;74(5):2633-2651
pubmed: 34110633
Biomed Mater. 2021 Feb 25;16(2):025026
pubmed: 32726764
Pharmaceuticals (Basel). 2020 Oct 19;13(10):
pubmed: 33086616
J Exp Clin Cancer Res. 2016 Sep 30;35(1):159
pubmed: 27716356
Oncol Res. 2017 May 24;25(5):651-661
pubmed: 27712599
Cancer Res. 2019 Jan 1;79(1):146-158
pubmed: 30401711
Endocr Relat Cancer. 2019 May;26(5):525-538
pubmed: 30870812
Life Sci. 2021 Jan 1;264:118687
pubmed: 33181174
Sci Rep. 2020 May 26;10(1):8686
pubmed: 32457479
Cancer Lett. 2003 Feb 10;190(1):105-12
pubmed: 12536083
Cell Physiol Biochem. 2016;38(5):1715-26
pubmed: 27160836
J Transl Med. 2020 Jan 8;18(1):12
pubmed: 31915008
Eur Rev Med Pharmacol Sci. 2016 Oct;20(20):4362-4368
pubmed: 27831634
Mol Ther Nucleic Acids. 2020 Sep 4;21:86-97
pubmed: 32516736
Cells. 2020 Dec 01;9(12):
pubmed: 33271820
J Cell Physiol. 2022 Jan;237(1):199-238
pubmed: 34431086
Cancer Sci. 2017 Jan;108(1):42-52
pubmed: 27762090
Front Cell Dev Biol. 2020 Dec 03;8:601953
pubmed: 33344455
J Cancer. 2018 Oct 18;9(21):4049-4057
pubmed: 30410610
Oncol Rep. 2019 Feb;41(2):1180-1188
pubmed: 30431139
Oncotarget. 2020 Oct 06;11(40):3633-3645
pubmed: 33088424
J Extracell Vesicles. 2019 Nov 20;9(1):1692401
pubmed: 31807236
Sci Rep. 2016 Apr 12;6:23978
pubmed: 27068479
J Cancer. 2020 Oct 18;11(24):7116-7126
pubmed: 33193874
Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):12-19
pubmed: 30419312
Life Sci. 2020 Dec 15;263:118525
pubmed: 33031826
Oncogene. 2020 Sep;39(39):6231-6244
pubmed: 32826951
Gastroenterol Res Pract. 2020 Dec 9;2020:8834359
pubmed: 33376485
J Recept Signal Transduct Res. 2022 Jun;42(3):268-278
pubmed: 34096448
Cell Prolif. 2020 Jul;53(7):e12833
pubmed: 32525231
Methods. 2015 Oct 1;87:46-58
pubmed: 26044649
Front Oncol. 2020 Dec 17;10:590492
pubmed: 33392086
Signal Transduct Target Ther. 2020 Aug 5;5(1):145
pubmed: 32759948
Adipocyte. 2019 Dec;8(1):31-45
pubmed: 30474469
Cell Death Dis. 2021 Apr 7;12(4):373
pubmed: 33828078
Neoplasia. 2020 Oct;22(10):511-521
pubmed: 32896761
Trends Cancer. 2021 Feb;7(2):122-133
pubmed: 33008796
Nat Rev Cancer. 2006 May;6(5):392-401
pubmed: 16572188
Biochem Pharmacol. 2010 Nov 15;80(10):1553-62
pubmed: 20699088
Cancers (Basel). 2021 Jan 17;13(2):
pubmed: 33477340
Cancers (Basel). 2020 Sep 30;12(10):
pubmed: 33007968
Molecules. 2017 Jul 11;22(7):
pubmed: 28696369
Biomolecules. 2019 Dec 31;10(1):
pubmed: 31906046
Biomolecules. 2019 Jul 07;9(7):
pubmed: 31284669
Genes (Basel). 2020 Aug 11;11(8):
pubmed: 32796761
Chem Asian J. 2020 Dec 1;15(23):3973-3982
pubmed: 33029906
Theranostics. 2021 Jan 1;11(3):1115-1128
pubmed: 33391524
Drug Des Devel Ther. 2020 Aug 25;14:3495-3507
pubmed: 32921986
Cancer Res. 2019 Feb 15;79(4):795-806
pubmed: 30610087
Cancer Res. 2018 Sep 15;78(18):5287-5299
pubmed: 30042153
Cell Death Dis. 2020 Sep 9;11(9):728
pubmed: 32908134
Int J Mol Sci. 2021 Mar 04;22(5):
pubmed: 33806361
Oncol Lett. 2020 Jul;20(1):589-600
pubmed: 32565984
Oncol Lett. 2018 May;15(5):6636-6640
pubmed: 29616126
Oncogene. 2021 Jun;40(23):3989-4003
pubmed: 33994542
Int J Mol Sci. 2021 May 11;22(10):
pubmed: 34064646
J Hepatol. 2017 Oct;67(4):739-748
pubmed: 28549917
Mol Biotechnol. 2021 Apr;63(4):249-266
pubmed: 33492613
Proteomics. 2019 Apr;19(8):e1800180
pubmed: 30672117
Biochem Biophys Res Commun. 2017 Oct 21;492(3):356-361
pubmed: 28851650
Life Sci. 2021 Jan 1;264:118623
pubmed: 33096118
J Cell Physiol. 2019 Aug;234(10):18249-18261
pubmed: 30851074
Signal Transduct Target Ther. 2020 Apr 29;5(1):41
pubmed: 32345959
Semin Cancer Biol. 2016 Oct;40-41:100-115
pubmed: 27019417
Appl Biochem Biotechnol. 2019 Jan;187(1):352-364
pubmed: 29951961
Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188574
pubmed: 34062154
Mol Ther Oncolytics. 2019 Oct 31;15:223-233
pubmed: 31828217
Life Sci. 2020 Dec 15;263:118523
pubmed: 33039386
J Exp Clin Cancer Res. 2016 Dec 1;35(1):186
pubmed: 27906043
Cancer Biother Radiopharm. 2020 Sep 7;:
pubmed: 32898433
PLoS One. 2020 May 5;15(5):e0225290
pubmed: 32369495
Cancers (Basel). 2020 Dec 10;12(12):
pubmed: 33321813
Mol Ther Nucleic Acids. 2018 Sep 7;12:229-241
pubmed: 30195762
Oncotarget. 2014 Apr 15;5(7):1897-911
pubmed: 24722367
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Int J Mol Sci. 2020 Sep 17;21(18):
pubmed: 32957712
PLoS One. 2013 Dec 31;8(12):e84256
pubmed: 24391924
Gene. 2019 Nov 30;719:144044
pubmed: 31400406
Oncotarget. 2017 Mar 14;8(11):17700-17711
pubmed: 27458171
Proteomics. 2009 May;9(10):2820-35
pubmed: 19415654
Exp Cell Res. 2020 Jun 15;391(2):111956
pubmed: 32169425
Front Cardiovasc Med. 2017 Oct 09;4:63
pubmed: 29062835
Semin Cancer Biol. 2021 Sep;74:62-78
pubmed: 33609665
J Proteome Res. 2018 Oct 5;17(10):3599-3605
pubmed: 30192545
Front Immunol. 2018 May 08;9:871
pubmed: 29867925
Phys Med. 2019 Aug;64:145-156
pubmed: 31515013
Lab Invest. 2021 May;101(5):612-624
pubmed: 33446893
Oral Oncol. 2021 Jun;117:105279
pubmed: 33819809
BioDrugs. 2020 Oct;34(5):567-586
pubmed: 32754790
Int J Cancer. 2020 Mar 15;146(6):1700-1716
pubmed: 31381140
Phytomedicine. 2019 Jun;59:152907
pubmed: 30981183
Cancer Res. 2017 Nov 1;77(21):5808-5819
pubmed: 28855213
Mol Cancer Res. 2018 Nov;16(11):1798-1808
pubmed: 30042174
Mol Med Rep. 2013 Jul;8(1):272-6
pubmed: 23652371
Onco Targets Ther. 2020 Jun 09;13:5293-5307
pubmed: 32606748
Circ Res. 2020 Jul 3;127(2):310-329
pubmed: 32833569
Oncogene. 2021 Jan;40(3):633-646
pubmed: 33208911
Carcinogenesis. 2021 Feb 11;42(1):38-47
pubmed: 32832992
Cancer Cell Int. 2021 Jun 24;21(1):319
pubmed: 34167524
Br J Cancer. 2017 Feb 28;116(5):609-619
pubmed: 28152544
J Cell Physiol. 2019 Dec;234(12):21493-21503
pubmed: 31144314
J Exp Clin Cancer Res. 2019 Sep 5;38(1):389
pubmed: 31488217
Am J Transl Res. 2020 Oct 15;12(10):6277-6289
pubmed: 33194029
Neoplasma. 2021 Jul;68(4):719-731
pubmed: 33847133
Biomed Res Int. 2020 Jul 8;2020:2125656
pubmed: 32695810
Front Cell Dev Biol. 2021 Mar 04;8:620603
pubmed: 33748098
J Ovarian Res. 2020 Jan 22;13(1):9
pubmed: 31969186
PLoS One. 2014 Dec 23;9(12):e114507
pubmed: 25536365
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Int J Biol Sci. 2019 Sep 7;15(11):2438-2447
pubmed: 31595161
Cell Biol Int. 2021 Apr;45(4):858-868
pubmed: 33325136
Clin Sci (Lond). 2019 Jul 5;133(13):1401-1419
pubmed: 31227603
Mol Cancer. 2019 May 7;18(1):91
pubmed: 31064356
J Extracell Vesicles. 2017 Sep 3;6(1):1368823
pubmed: 28959385
Cells. 2021 Jan 08;10(1):
pubmed: 33429910
Braz J Med Biol Res. 2017 Nov 13;51(1):e6472
pubmed: 29160412
Exp Biol Med (Maywood). 2020 Mar;245(5):486-497
pubmed: 32050794
J Adv Res. 2020 Jul 13;26:83-94
pubmed: 33133685
Mol Ther. 2018 Mar 7;26(3):774-783
pubmed: 29456019
Cell Commun Signal. 2020 Mar 17;18(1):46
pubmed: 32183816
Cell Signal. 2019 Nov;63:109385
pubmed: 31394194
Cancer Gene Ther. 2021 Apr;28(3-4):250-264
pubmed: 33299140
Cancers (Basel). 2020 Aug 15;12(8):
pubmed: 32824235
Biomaterials. 2021 Jun;273:120784
pubmed: 33848731
Cold Spring Harb Perspect Biol. 2014 May 22;6(10):a016857
pubmed: 24851870
J Hematol Oncol. 2020 Nov 10;13(1):152
pubmed: 33168028
Onco Targets Ther. 2019 Apr 11;12:2777-2787
pubmed: 31114227
Expert Opin Pharmacother. 2020 Sep;21(13):1579-1590
pubmed: 32552175
J Control Release. 2017 Nov 28;266:8-16
pubmed: 28916446
Biomed Pharmacother. 2021 Jun;138:111529
pubmed: 34311529
Oxid Med Cell Longev. 2021 May 28;2021:5529484
pubmed: 34194604
Cancer Sci. 2021 Apr;112(4):1457-1470
pubmed: 33511729
Cell Prolif. 2021 Feb;54(2):e12974
pubmed: 33382511
Cancer Commun (Lond). 2020 Sep;40(9):435-452
pubmed: 32720740
Theranostics. 2019 Feb 28;9(6):1714-1727
pubmed: 31037133
Cell Biosci. 2021 Mar 31;11(1):63
pubmed: 33789726
J Cell Mol Med. 2020 Jan;24(2):1529-1540
pubmed: 31894895
J Surg Oncol. 2017 Jun;115(8):932-940
pubmed: 28334432
Biomed Environ Sci. 2018 Mar;31(3):171-185
pubmed: 29673440
Front Cell Dev Biol. 2021 Jul 19;9:653808
pubmed: 34350172
Biochem J. 2004 May 15;380(Pt 1):161-71
pubmed: 14965343
Biochem Biophys Res Commun. 2020 Dec 10;533(3):368-375
pubmed: 32962858
Immunol Invest. 2022 Jul;51(5):1423-1436
pubmed: 34251965
Int J Mol Sci. 2017 May 19;18(5):
pubmed: 28534824
Mol Ther Nucleic Acids. 2020 Nov 26;24:92-103
pubmed: 33738141
Aging (Albany NY). 2021 Apr 21;13(8):11808-11821
pubmed: 33883305
Development. 1988 Mar;102(3):471-8
pubmed: 2460305
Trends Pharmacol Sci. 2016 Jul;37(7):606-617
pubmed: 27157716
Oncogene. 2020 Oct;39(40):6354-6369
pubmed: 32855524
Cancer Sci. 2019 Jul;110(7):2119-2132
pubmed: 31141251
Semin Cancer Biol. 2022 May;80:205-217
pubmed: 32450139
Biomaterials. 2021 Jul;274:120894
pubmed: 34029916
Cell Biochem Funct. 2021 Mar;39(2):308-316
pubmed: 32876972
Nanomedicine. 2018 Jan;14(1):195-204
pubmed: 28982587
Mol Ther. 2019 Oct 2;27(10):1772-1783
pubmed: 31416776
Life Sci. 2020 Sep 1;256:117899
pubmed: 32504749
Cancer Manag Res. 2020 Nov 18;12:11823-11832
pubmed: 33244265
J Natl Cancer Inst. 2017 Jan 25;109(6):
pubmed: 28122908
Int J Biol Macromol. 2020 Oct 15;161:470-480
pubmed: 32531356
Front Oncol. 2020 Jul 14;10:960
pubmed: 32760666
Neurooncol Adv. 2020 May 06;2(1):vdaa056
pubmed: 32642708
Nanomedicine. 2018 Oct;14(7):1973-1985
pubmed: 29935333
IUBMB Life. 2020 Aug;72(8):1705-1714
pubmed: 32344463
Cancers (Basel). 2018 Jul 10;10(7):
pubmed: 29996471
Biochim Biophys Acta. 2012 Jul;1820(7):940-8
pubmed: 22503788
Mol Ther Nucleic Acids. 2020 Mar 6;19:654-667
pubmed: 31955007
J Cell Physiol. 2021 Dec;236(12):7938-7965
pubmed: 34105151
Mol Ther Nucleic Acids. 2020 Nov 17;23:355-368
pubmed: 33425493
Mol Oncol. 2021 Jan;15(1):3-26
pubmed: 33207034
Eur J Pharmacol. 2020 Aug 15;881:173226
pubmed: 32485246
Acta Biochim Biophys Sin (Shanghai). 2020 Dec 29;52(12):1299-1305
pubmed: 33355355
Biochem Pharmacol. 2021 Jul;189:114432
pubmed: 33513339
BMC Cancer. 2020 Oct 14;20(1):996
pubmed: 33054752
Life Sci. 2021 Nov 1;284:119222
pubmed: 33609542
Cancer Res. 2019 May 1;79(9):2152-2166
pubmed: 30635277
Curr Cancer Drug Targets. 2021;21(1):2-20
pubmed: 33069197
Aging (Albany NY). 2020 Oct 11;12(19):19660-19676
pubmed: 33040049
Mol Pharm. 2018 May 7;15(5):1892-1900
pubmed: 29595984
J Oncol. 2021 Jun 21;2021:3874478
pubmed: 34239562
PLoS One. 2014 Feb 18;9(2):e88685
pubmed: 24558412
FASEB J. 2020 Feb;34(2):3379-3398
pubmed: 31922312
Signal Transduct Target Ther. 2020 Apr 22;5(1):39
pubmed: 32317629
Curr Drug Metab. 2019;20(10):804-814
pubmed: 31424364
Biomed Res Int. 2020 Apr 6;2020:7461727
pubmed: 32337272
Theranostics. 2019 Jan 30;9(4):1001-1014
pubmed: 30867812
J Cancer Res Clin Oncol. 2017 Jun;143(6):991-1004
pubmed: 28285404
Breast Cancer. 2021 Jul;28(4):829-837
pubmed: 33770377
Nat Commun. 2020 Dec 22;11(1):6438
pubmed: 33353933
Lab Chip. 2016 Dec 20;17(1):11-33
pubmed: 27830852
J Biomed Nanotechnol. 2019 Nov 1;15(11):2202-2208
pubmed: 31847934
Epigenomics. 2019 Feb;11(4):411-421
pubmed: 30785332
Nat Commun. 2020 Nov 2;11(1):5513
pubmed: 33139730
Int J Hyperthermia. 2020;37(1):696-710
pubmed: 32568583
Molecules. 2019 Apr 22;24(8):
pubmed: 31013639
PLoS One. 2012;7(3):e32476
pubmed: 22427843
Sci Rep. 2021 Jul 8;11(1):14141
pubmed: 34238972
J Extracell Vesicles. 2018 Jun 04;7(1):1481321
pubmed: 29887978
Antioxid Redox Signal. 2021 Jun 20;34(18):1484-1497
pubmed: 33198508
Sci Rep. 2019 Nov 11;9(1):16497
pubmed: 31712601
Bratisl Lek Listy. 2020;121(1):31-36
pubmed: 31950837
Lancet. 2016 Jul 30;388(10043):518-29
pubmed: 26853587
Methods Mol Biol. 2020;2067:175-188
pubmed: 31701453
Int Immunol. 2021 Mar 1;33(3):127-148
pubmed: 33337480
Sci Rep. 2020 Feb 26;10(1):3508
pubmed: 32103099
Mol Oncol. 2021 May;15(5):1543-1565
pubmed: 33605506
J Exp Clin Cancer Res. 2020 Jul 22;39(1):140
pubmed: 32698859
Cancer Res. 2016 Dec 1;76(23):6816-6827
pubmed: 27760789
Cell Death Dis. 2018 Mar 22;9(4):434
pubmed: 29567987
Nat Commun. 2020 Oct 8;11(1):5060
pubmed: 33033246
Mol Cancer Ther. 2016 Dec;15(12):2966-2976
pubmed: 27765853
Gut. 2021 Nov;70(11):2123-2137
pubmed: 33318144
Am J Transl Res. 2021 Jun 15;13(6):6001-6015
pubmed: 34306340
Nat Rev Cancer. 2013 Oct;13(10):714-26
pubmed: 24060863
Cancers (Basel). 2018 Nov 08;10(11):
pubmed: 30413072
Nat Rev Drug Discov. 2017 Sep;16(9):635-661
pubmed: 28529319
Gut. 2020 Nov 10;:
pubmed: 33172926
Bull Cancer. 2018 Apr;105(4):336-349
pubmed: 29496262
Mol Cancer. 2017 May 23;16(1):94
pubmed: 28535767
Blood. 1999 Dec 1;94(11):3791-9
pubmed: 10572093
Cell Signal. 2021 Aug;84:110029
pubmed: 33932496
J Mol Med (Berl). 2014 Mar;92(3):267-76
pubmed: 24233024
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
Pharmacol Ther. 2021 Feb;218:107670
pubmed: 32891711
Cancer. 2019 Apr 15;125(8):1228-1246
pubmed: 30748003
Br J Pharmacol. 2017 Dec;174(24):4684-4700
pubmed: 28736855
Cancer Manag Res. 2020 Dec 16;12:12965-12974
pubmed: 33364842
Biomolecules. 2021 Feb 18;11(2):
pubmed: 33670518
Oncotarget. 2021 Feb 02;12(3):185-198
pubmed: 33613846
EXCLI J. 2019 Oct 09;18:899-907
pubmed: 31645849
Tumour Biol. 2015 Sep;36(9):6633-44
pubmed: 26242271
Biochem Biophys Res Commun. 2018 Jan 1;495(1):71-77
pubmed: 29111329
Int J Mol Sci. 2021 Jan 27;22(3):
pubmed: 33513976
Med Sci Monit. 2018 Apr 18;24:2350-2359
pubmed: 29668670
Med Res Rev. 2020 Dec 1;:
pubmed: 33289118
Clin Cancer Res. 2019 Mar 15;25(6):1936-1947
pubmed: 30610103
Cancer Treat Rev. 2018 Jan;62:29-38
pubmed: 29154023
Biosci Rep. 2020 Nov 27;40(11):
pubmed: 33146702
N Engl J Med. 1971 Nov 18;285(21):1182-6
pubmed: 4938153
Life Sci. 2021 Feb 1;266:118871
pubmed: 33309716
Front Immunol. 2020 Oct 09;11:2026
pubmed: 33162971
Cancer Lett. 2021 Jul 1;509:63-80
pubmed: 33838282
Cancer Cell Int. 2021 Jan 15;21(1):55
pubmed: 33451320
Cell Mol Neurobiol. 2020 Jul;40(5):767-784
pubmed: 31853695
Oncogene. 2012 Aug 16;31(33):3754-63
pubmed: 22179825
Oncol Rep. 2018 Dec;40(6):3438-3446
pubmed: 30542738
Am J Transl Res. 2020 Oct 15;12(10):6811-6826
pubmed: 33194074
PeerJ. 2021 Apr 13;9:e11200
pubmed: 33954040
Int J Mol Sci. 2019 Jan 14;20(2):
pubmed: 30646616
Clin Exp Metastasis. 2014 Oct;31(7):805-15
pubmed: 25253431
J Hematol Oncol. 2015 Oct 29;8:122
pubmed: 26514126
Cells. 2020 Dec 22;10(1):
pubmed: 33375076
J Mol Diagn. 2020 Aug;22(8):1096-1108
pubmed: 32535085
Front Pharmacol. 2018 Dec 04;9:1294
pubmed: 30564115
Methods Mol Biol. 2017;1660:25-32
pubmed: 28828645
Oncogenesis. 2017 Jun 26;6(6):e351
pubmed: 28650446
Methods Mol Biol. 2015;1295:179-209
pubmed: 25820723
Stem Cells Dev. 2019 Apr 1;28(7):464-476
pubmed: 30717632
Urology. 2016 May;91:241.e1-7
pubmed: 26876462
Lab Chip. 2014 Oct 7;14(19):3773-80
pubmed: 25099143
J Exp Clin Cancer Res. 2018 Jul 31;37(1):177
pubmed: 30064461
Annu Rev Physiol. 2016;78:67-83
pubmed: 26667071
Nat Commun. 2021 Jun 10;12(1):3543
pubmed: 34112803
J Biochem. 2020 Nov 1;168(5):491-498
pubmed: 32770182
Adv Healthc Mater. 2021 Mar;10(5):e2001294
pubmed: 33615743
PLoS One. 2018 Nov 1;13(11):e0206759
pubmed: 30383833
J Cell Biochem. 2020 Jun;121(5-6):3286-3297
pubmed: 31960989
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188475
pubmed: 33188876
J Clin Med. 2019 Jul 02;8(7):
pubmed: 31269723
Front Cell Dev Biol. 2020 Dec 09;8:608521
pubmed: 33363169
Mol Ther Nucleic Acids. 2019 Sep 6;17:448-451
pubmed: 31323464
Elife. 2021 Jan 06;10:
pubmed: 33404012
Cells. 2020 Jun 21;9(6):
pubmed: 32575858
Tumour Biol. 2016 Sep;37(9):12169-12180
pubmed: 27220495
Int J Clin Exp Pathol. 2019 Jul 01;12(7):2485-2495
pubmed: 31934075
Lab Chip. 2017 Oct 25;17(21):3558-3577
pubmed: 28832692
Oncol Rep. 2017 Aug;38(2):785-798
pubmed: 28656228
Dev Biol. 1995 Jun;169(2):699-712
pubmed: 7781909
Biomed Res Int. 2021 Jun 29;2021:5516078
pubmed: 34307654
Cell Biol Int. 2021 Jul;45(7):1510-1522
pubmed: 33728699
Cancer Lett. 2018 Oct 28;435:80-91
pubmed: 30098399
Front Med (Lausanne). 2021 Apr 27;8:619939
pubmed: 33987190
Mol Ther. 2021 Mar 3;29(3):1226-1238
pubmed: 33221435
J Cell Mol Med. 2020 Dec;24(24):14467-14480
pubmed: 33145980
J Biol Chem. 2020 Oct 2;295(40):13737-13752
pubmed: 32709750
Mol Cancer. 2018 Oct 6;17(1):146
pubmed: 30292233
Sci Rep. 2017 Dec 20;7(1):17925
pubmed: 29263330
Exp Neurol. 2020 Sep;331:113363
pubmed: 32450192
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188423
pubmed: 32871244
Cancer Lett. 2018 Sep 28;432:260-271
pubmed: 29920292
Dig Dis Sci. 2021 Aug;66(8):2637-2650
pubmed: 32910366
Oncol Lett. 2021 Apr;21(4):249
pubmed: 33664813
J Cell Physiol. 2019 Jul;234(7):10602-10614
pubmed: 30417360
Oncogene. 2018 Jul;37(28):3806-3821
pubmed: 29636548
Cell Mol Life Sci. 2019 May;76(10):1947-1966
pubmed: 30879091
Cancers (Basel). 2019 Feb 22;11(2):
pubmed: 30813295
Cancer Cell Int. 2018 Oct 22;18:164
pubmed: 30377411
Int J Mol Sci. 2021 Feb 22;22(4):
pubmed: 33671527
Life Sci. 2021 Jul 15;277:119430
pubmed: 33789144
Front Pharmacol. 2018 May 30;9:531
pubmed: 29899697
Theranostics. 2021 Jan 1;11(3):1429-1445
pubmed: 33391543
Pharmacol Res. 2021 Mar;165:105442
pubmed: 33497805
Cancer Lett. 2018 Sep 1;431:190-200
pubmed: 29800682
Pathol Res Pract. 2020 Nov;216(11):153144
pubmed: 32911346
J Nanobiotechnology. 2020 Jan 9;18(1):10
pubmed: 31918721
Oncogene. 2018 May;37(21):2873-2889
pubmed: 29520105
Adv Sci (Weinh). 2021 Jul;8(13):e2101458
pubmed: 34051063
Sci Rep. 2020 Dec 8;10(1):21412
pubmed: 33293585
Gene. 2017 Aug 5;623:5-14
pubmed: 28438694
J Recept Signal Transduct Res. 2022 Apr;42(2):109-116
pubmed: 33307912
Blood Adv. 2017 May 16;1(13):812-823
pubmed: 29296725
Sci Adv. 2020 Oct 9;6(41):
pubmed: 33036977
J Vis Exp. 2018 Dec 5;(142):
pubmed: 30582600
J Cell Mol Med. 2021 Feb;25(3):1568-1582
pubmed: 33410581
J Cell Biochem. 2019 Jan;120(1):988-999
pubmed: 30160795
Cell Mol Life Sci. 2018 Mar;75(6):1071-1098
pubmed: 29116363
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16157-62
pubmed: 19805273
J Nanobiotechnology. 2018 Dec 20;16(1):103
pubmed: 30572882
PLoS One. 2017 Jan 20;12(1):e0169932
pubmed: 28107450
J Gene Med. 2018 Apr;20(4):e3010
pubmed: 29424105
Cancers (Basel). 2021 Apr 14;13(8):
pubmed: 33919917
Biomaterials. 2021 Feb;269:120467
pubmed: 33189359
Int J Mol Sci. 2021 Feb 22;22(4):
pubmed: 33671587
J Surg Res. 2015 Jun 1;196(1):39-48
pubmed: 25819770
Biomedicines. 2020 Aug 03;8(8):
pubmed: 32756305
Sci Rep. 2016 Nov 28;6:37982
pubmed: 27892494
Cancers (Basel). 2021 Mar 17;13(6):
pubmed: 33802764
Cell Immunol. 2021 Feb;360:104262
pubmed: 33373818
J Cell Biochem. 2020 Mar;121(3):2525-2533
pubmed: 31646690
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
Biomed Res Int. 2019 May 21;2019:2595801
pubmed: 31240207
Cell Biosci. 2019 Aug 6;9:62
pubmed: 31402975
Stem Cell Res Ther. 2019 Apr 11;10(1):117
pubmed: 30971292
Cancer Lett. 2021 Aug 10;513:1-13
pubmed: 34010715
Antibodies (Basel). 2020 Dec 01;9(4):
pubmed: 33271774
Stem Cells Int. 2020 Dec 13;2020:8890201
pubmed: 33414831
Biosci Rep. 2020 Jul 31;40(7):
pubmed: 32463473
J Immunol. 2020 Nov 15;205(10):2916-2925
pubmed: 32989094
Mol Pharm. 2021 Aug 2;18(8):3010-3025
pubmed: 34176265
Lab Invest. 2018 Sep;98(9):1133-1142
pubmed: 29967342
Elife. 2019 May 28;8:
pubmed: 31134894
Pharmacol Res. 2019 Dec;150:104504
pubmed: 31678208
J Biol Chem. 2014 Dec 5;289(49):34296-307
pubmed: 25320076
Diagnostics (Basel). 2020 Dec 31;11(1):
pubmed: 33396213
Cancer Lett. 2021 Oct 1;517:66-77
pubmed: 34111513
Hepatology. 2014 May;59(5):1874-85
pubmed: 24259426
Biochim Biophys Acta Proteins Proteom. 2019 Dec;1867(12):140203
pubmed: 30822540
Onco Targets Ther. 2020 Nov 23;13:12055-12066
pubmed: 33262606
Cell Mol Life Sci. 2020 Nov;77(22):4459-4483
pubmed: 32358622
Kidney Int. 2012 Nov;82(9):1024-32
pubmed: 22785172
J Extracell Vesicles. 2015 Jul 17;4:27031
pubmed: 26194179
Carcinogenesis. 2021 Jun 21;42(6):831-841
pubmed: 33928340
Viruses. 2015 Sep 17;7(9):5066-83
pubmed: 26393640
J Nippon Med Sch. 2020 Dec 14;87(5):244-251
pubmed: 32475898
Pharmacol Rep. 2020 Oct;72(5):1125-1151
pubmed: 32700248
Oncotarget. 2016 Aug 23;7(34):54852-54866
pubmed: 27363026
Cancers (Basel). 2020 Jan 18;12(1):
pubmed: 31963677
Cancer Lett. 2018 Sep 1;431:123-141
pubmed: 29857127
Mol Med Rep. 2020 Oct;22(4):2941-2947
pubmed: 32945400
Tumour Biol. 2014 May;35(5):3945-51
pubmed: 24420150
Exp Biol Med (Maywood). 2021 Sep;246(17):1895-1906
pubmed: 33969722
J Cancer. 2020 May 25;11(16):4724-4735
pubmed: 32626519
Front Immunol. 2019 Sep 04;10:2103
pubmed: 31555295
Appl Microbiol Biotechnol. 2019 Dec;103(23-24):9569-9582
pubmed: 31701195
Drug Dev Ind Pharm. 2020 Jul;46(7):1150-1162
pubmed: 32482115
Angiogenesis. 2020 Nov;23(4):599-610
pubmed: 32419057
Biomolecules. 2020 Oct 05;10(10):
pubmed: 33027960
Cancer Lett. 2020 May 1;477:41-48
pubmed: 32112905
Ci Ji Yi Xue Za Zhi. 2019 Dec 05;32(2):113-120
pubmed: 32269942
Cancer Prev Res (Phila). 2013 Aug;6(8):843-54
pubmed: 23803415
Cancer Gene Ther. 2018 Oct;25(9-10):248-259
pubmed: 29983418
J Cell Mol Med. 2020 Dec;24(23):13984-13990
pubmed: 33155413
Biomedicines. 2018 Jul 27;6(3):
pubmed: 30060453
Nat Commun. 2020 Aug 13;11(1):4053
pubmed: 32792481
Anticancer Res. 2020 Jun;40(6):3091-3096
pubmed: 32487603
Front Cell Dev Biol. 2021 May 21;9:679185
pubmed: 34095151
IUBMB Life. 2020 Sep;72(9):1930-1940
pubmed: 32542981
Oncotarget. 2016 Jul 12;7(28):44462-44477
pubmed: 27286448
Cancer Biother Radiopharm. 2022 Mar;37(2):96-110
pubmed: 32783691
Ann N Y Acad Sci. 2015 Jul;1347:45-51
pubmed: 25773744
Oncotarget. 2017 Feb 21;8(8):12831-12842
pubmed: 28086233
Oncogene. 2017 Feb 2;36(5):639-651
pubmed: 27345402
Int J Mol Sci. 2020 Nov 28;21(23):
pubmed: 33260642
J Cancer. 2019 Jul 23;10(18):4397-4407
pubmed: 31413760
Int J Biochem Cell Biol. 2019 Mar;108:17-20
pubmed: 30630112
Molecules. 2018 Jul 02;23(7):
pubmed: 30004418
Stem Cell Rev Rep. 2021 Jun;17(3):1027-1038
pubmed: 33410095
Cells. 2019 May 17;8(5):
pubmed: 31108880
FEBS Lett. 2017 Jul;591(14):2167-2179
pubmed: 28643334
Cancer. 2002 Nov 15;95(10):2196-201
pubmed: 12412174
Semin Cancer Biol. 2021 Feb;69:5-23
pubmed: 31421264
Mol Oncol. 2021 Dec;15(12):3430-3446
pubmed: 34213835
Cancer Med. 2020 Oct;9(19):7205-7217
pubmed: 32762035
Oncol Lett. 2020 Oct;20(4):31
pubmed: 32774504
J Cell Sci. 2000 Oct;113 Pt 19:3365-74
pubmed: 10984428
Int J Nanomedicine. 2017 May 15;12:3721-3733
pubmed: 28553110
Cytotherapy. 2018 Feb;20(2):181-188
pubmed: 29269240
J Oncol. 2019 May 2;2019:2476175
pubmed: 31186629
Cancer Lett. 2015 Jul 10;363(1):28-36
pubmed: 25827070
Cancer Biother Radiopharm. 2021 Mar 3;:
pubmed: 33661058
Phytomedicine. 2021 Jul;87:153574
pubmed: 34006448
Cancer Res. 2021 Jan 1;81(1):114-128
pubmed: 33158815
Asian J Pharm Sci. 2020 Jul;15(4):461-471
pubmed: 32952669
Oncol Rep. 2017 Jul;38(1):522-528
pubmed: 28586039
Onco Targets Ther. 2019 Dec 11;12:10827-10839
pubmed: 31849488
PLoS One. 2017 Jan 23;12(1):e0170628
pubmed: 28114422
Cancer Lett. 2021 Jun 28;508:104-114
pubmed: 33766750
Traffic. 2009 Jul;10(7):925-37
pubmed: 19490536

Auteurs

Mahshid Deldar Abad Paskeh (MDA)

Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Maliheh Entezari (M)

Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Sepideh Mirzaei (S)

Department of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, Iran.

Amirhossein Zabolian (A)

Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Hossein Saleki (H)

Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Mohamad Javad Naghdi (MJ)

Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Sina Sabet (S)

Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Mohammad Amin Khoshbakht (MA)

Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Mehrdad Hashemi (M)

Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Kiavash Hushmandi (K)

Division of Epidemiology, Department of Food Hygiene and Quality Control, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.

Gautam Sethi (G)

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore.
NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.

Ali Zarrabi (A)

Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Istinye University, 34396, Istanbul, Turkey.

Alan Prem Kumar (AP)

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore.
NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.

Shing Cheng Tan (SC)

UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. sctan@ukm.edu.my.

Marios Papadakis (M)

Department of Surgery II, University Hospital Witten-Herdecke, University of Witten-Herdecke, Heusnerstrasse 40, 42283, Wuppertal, Germany. marios_papadakis@yahoo.gr.

Athanasios Alexiou (A)

Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, Australia.
AFNP Med Austria, Vienna, Austria.

Md Asiful Islam (MA)

Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, B15 2TT, UK.

Ebrahim Mostafavi (E)

Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.

Milad Ashrafizadeh (M)

Faculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, Üniversite Caddesi No. 27, Orhanlı, Tuzla, Istanbul, Turkey. milad.ashrafizadeh@sabanciuniv.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH